Olivia Wakefield is an experienced strategic advisor and business leader, providing trusted counsel to Boards of Directors and senior executive leadership with deep experience developing and implementing executive compensation and total reward strategies to enable business performance and drive results. As a Partner in the Boston Office, Olivia brings extensive executive compensation advisory experience and a unique perspective fostered by 25 years in both consulting and corporate roles. Olivia’s executive compensation expertise includes executive compensation strategy, incentive design, equity program design, preparation for IPO, divestiture, acquisition and other transactions, investor engagement and disclosure support, retention, and severance / change-in-control programs. Earlier in her career, Olivia founded the life sciences executive compensation practice at Willis Towers Watson. She then went on to address complex executive compensation and total rewards issues as the Global Head of Total Rewards at Shire and the SVP, Global Head of Total Rewards at Takeda (which acquired Shire). Olivia has experience in supporting Boards of Directors and senior management with global expertise that spans the United States, Europe and Asia. During her career, Olivia has served as the Board-appointed executive compensation advisor across many industries with a specialized focus on biotech, biopharma, pharmaceutical, medical device and healthcare companies at all stages of development.